Screener
Stereotaxis STXS Q2 2026 earnings
Reported August 11, 2026 · After market close
Revenue$7.7MMiss by $680.0K
EPS-$0.05In line
Revenue estimate$8.4M
EPS estimate-$0.05
“Stereotaxis has reached an important commercial inflection point. Following years of product development and regulatory milestones, the Company's expanded robotic platform is now generating accelerating commercial adoption across multiple product lines. Over the last several years we advanced an exciting ecosystem of robotic, catheter and digital innovations through development and regulatory milestones. We are now witnessing the initial green shoots of commercial success, including quarterly revenue from our novel robotic catheters exceeding one million dollars, the first Synchrony system sales, and the first US purchase of a GenesisX robot.”
Next report
Nov 10, 2026 (in 2 months)Revenue estimate$9.9M
EPS estimate-$0.05
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Stereotaxis report Q2 2026 earnings?
- Stereotaxis (STXS) reported Q2 2026 earnings on August 11, 2026 after market close.
- What were Stereotaxis's Q2 2026 revenue and EPS?
- Stereotaxis reported revenue of $7.7M and eps of $-0.05 for Q2 2026.
- Did Stereotaxis beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $8.4M by $680.0K. EPS beat the consensus estimate of $-0.05 by $0.00.
- How did Stereotaxis's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 12.8% from $8.8M a year earlier and eps grew 0.0% from $-0.05.
- Where can I find Stereotaxis's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-037113) and the 10-Q periodic report (0001493152-26-037357) directly on SEC EDGAR. The filing index links above go to sec.gov.
